Skip to search formSkip to main contentSkip to account menu

Tumor-Associated Trypsin Inhibitor

Known as: Trypsin Inhibitor, Tumor Associated, Tumor Associated Trypsin Inhibitor, Trypsin Inhibitor, Tumor-Associated 
National Institutes of Health

Related topics

Related topics

3 relations
Pancreatic Trypsin Secretory Inhibitor, KazalSPINK1 gene

Broader (1)

Protein secretory trypsin inhibitor

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Su1252 Factors Predictive of Relapse, Cancer and Cyst Formation in Autoimmune Pancreatitis Patients
2012
2012
Su1251 Overexpression of EGFR in the Exocrine Pancreas Induces a Chronic Pancreatitis
Review
2011
Review
2011
Roles of serine protease inhibitor Kazal type 1 (SPINK1) in pancreatic diseases.
Serine protease inhibitor Kazal type 1 (SPINK1) was originally identified as a trypsin inhibitor by Kazal et al. in 1948. SPINK1… 
2011
2011
Abstract 915: Serine protease inhibitor Kazal type 1 promote a carcinogenesis of the colon
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL Colorectal cancer (CRC) is one of the most serious… 
2010
2010
Abstract 3116: Serine protease inhibitor Kazal type 1 plays a role of colon carcinogenesis through the epidermal growth factor receptor
Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC Serine protease inhibitor Kazal type 1 (SPINK1… 
2007
2007
ROLE OF ESTROGEN RECEPTOR BETA IN MOUSE PROSTATE AND BLADDER WITH REFERENCES TO HUMAN DISEASES
After the discovery of estrogen receptor beta (ERβ) in 1995, it became clear that in many “non-classical” estrogen-responsive… 
2005
2005
Identifizierung und Charakterisierung einer protektiven Trypsin-Mutante
1998
1998
Serum levels of tumor associated trypsin inhibitor (TATI) and glomerular filtration rate.
TATI (tumor associated trypsin inhibitor) is a low molecular weight protein employed as a tumor marker. To evaluate the role of… 
1992
1992
Squamous cell carcinoma antigen, tumor associated trypsin inhibitor and tissue polypeptide specific antigen in follow up of stage III cervical cancer.
189 clinical and serological examinations were performed in 30 patients before treatment and during follow up of squamous cell… 
1990
1990
A comparison of the usefulness of serum measurements of CA 125, CA 50 and TATI in patients with malignant and benign gynecological pathology.
CA 125, CA 50 and Tumor Associated Trypsin Inhibitor (TATI) levels were assayed in blood samples drawn at diagnosis from 149… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)